Skip to main content

What the FDA labels say about taking them together

Darunavir and propafenone

Darunavir's FDA label of August 29, 2025 names propafenone in its drug interactions section; the propafenone label PlainMeds reads does not name darunavir. The darunavir label: “Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics when co-administered with PREZISTA/ritonavir.”

Check it at the source: the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP); the propafenone FDA label on DailyMed (effective September 1, 2025, Strides Pharma Science Limited).

What does the darunavir label say about propafenone?

Darunavir label, drug interactions

Concomitant Drug Class Drug Name Examples: Other antiarrhythmics e.g. amiodarone, bepridil, disopyramide, flecainide, lidocaine (systemic), mexiletine, propafenone, quinidine; Effect on Concentration of Darunavir Or Concomitant Drug: ↑ antiarrhythmics; Clinical Comment: Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics when co-administered with PREZISTA/ritonavir.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

What does the propafenone label say about darunavir?

Propafenone's label (effective September 1, 2025) does not name darunavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PROPAFENONE HYDROCHLORIDE), Strides Pharma Science Limited, effective September 1, 2025 (SPL set c65253ab-937f-4982-b841-69c2b9f9ccdb), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Darunavir generic labelers
14Propafenone generic labelers
DarunavirPropafenone
Labeled forHIVAtrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)$1.16 per tablet 600 mg tablet$0.115 per tablet 150 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?